SPG4 (SPAST gene mutations) is the most common autosomal dominant form of hereditary spastic paraplegia, accounting for 40-45% of all AD-HSP cases. The SPAST gene encodes spastin, a microtubule-severing ATPase critical for axonal microtubule dynamics and maintenance of corticospinal tract integrity. This patient's clinical presentation (progressive lower limb spasticity, hyperreflexia, ankle clonus, bilateral Babinski signs, normal MRI, and SPAST mutation) is pathognomonic for SPG4/AD-HSP. Understanding the relative frequency of SPG4 among AD-HSP subtypes is essential for genetic counseling and anticipating disease course in Indian populations where HSP prevalence is 1-9 per 100,000.
GeneReviews HSP 2024; Brain 2023
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.